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ABSTRACT
Medical management of abdominal abscesses in horses requires prolonged antibiotic therapy and presents varied success rates. 
A 6-year-old male horse with a history of colic and multiple abdominal punctures to relieve gas was attended. At admission, 
tachycardia, tachypnea, hyperthermia, mucosal congestion, dehydration, and rigid gait were observed. The association of physical 
examination, laboratory and ultrasonographic findings allowed the diagnoses of peritonitis and abdominal abscess. Supporting 
treatment plus broad spectrum antibiotic therapy was performed: daily intraperitoneal ceftriaxone (25 mg/kg, 7 days); daily 
intravenous gentamicin (6.6 mg/kg, 7 days); per os metronidazole three times a day (15 mg/kg 12 days), followed by the same 
dose twice a day (15 mg/kg 33 days), totaling 45 days of treatment. Plasma fibrinogen and ultrasonographic examination 
were the most effective tools to evaluate abscess evolution. There was normalization of the physical examination 24 h after 
beginning the treatment, consecutive regression of the nucleated cell count in the peritoneal fluid, and regression of plasma 
fibrinogen and size of the abscess. On the 10th treatment day, the animal was discharged from the hospital, maintaining oral 
therapy with metronidazole every 12 h (15 mg / kg). When the animal returned on the 30th day, an abscess size regression was 
observed. However, there was no resolution, and therapy with metronidazole was maintained. On the 45th day of treatment, 
a new hospital evaluation was performed, where the abscess resolved, and metronidazole was suspended. It is highlighted 
that the therapeutic association used in the treatment of abdominal infection and abscess resulted in a rapid clinical response.
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RESUMO
O tratamento conservativo dos abscessos abdominais em equinos requer antibioticoterapia prolongada e apresenta variadas 
taxas de sucesso. Foi atendido um cavalo de seis anos de idade, com histórico de cólica e múltiplas punções abdominais 
por agulha para esvaziamento de gás. Na admissão, foram observados taquicardia, taquipnéia, hipertermia, congestão 
mucosa, desidratação e marcha rígida. A associação do exame físico, achados laboratoriais e ultrassonográficos permitiu o 
diagnóstico de peritonite e abscesso abdominal. Foi realizado tratamento suporte e antibioticoterapia de amplo espectro: 
ceftriaxona intraperitoneal diária (25 mg/kg, 7 dias); gentamicina intravenosa diária (6,6 mg/kg, 7 dias); metronidazol 
oral três vezes ao dia (15 mg/kg, 12 dias), seguido de mesma dose duas vezes ao dia, por mais 33 dias, totalizando 45 dias 
de tratamento. O fibrinogênio plasmático e o exame ultrassonográfico foram os recursos mais eficazes para a avaliação 
da evolução do abscesso. Após 24 horas do início do tratamento foi constatada a normalização do exame fisico, regressão 
progressiva da contagem de células nucleadas no líquido peritoneal, do fibrinogênio plasmático e do tamanho do abscesso. 
No 10° dia de tratamento o animal recebeu alta hospitalar, mantendo-se a terapia oral com metronidazol a cada 12 horas 
(15 mg/Kg). Em retorno, ao 30° dia, observou-se regressão do tamanho do abscesso, entretanto, não houve resolução, 
tendo sido mantida a terapia com metronidazol. No 45º dia de tratamento, realizou-se nova avaliação hospitalar, onde foi 
observada a resolução do abscesso e a admnistração do metronidazol foi suspensa. Destaca-se, que a associação terapêutica 
utilizada no tratamento de infecção abdominal e abscesso resultou em rápida resposta clínica.
Palavras-chave: Cavalos. Fibrinogênio. Infecção abdominal. Ultrassom abdominal. Via intraperitoneal.
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Introduction
Abdominal abscesses may develop from different etiologies, 
either by hematogenous or lymphatic bacterial dissemination, 
gastrointestinal perforation or devitalization, or previous 
abdominal surgery (Arnold & Chaffin, 2012; Berlin et al., 
2013; Elce, 2006). The diagnosis of abdominal abscesses is 
challenging due to anatomical location and nonspecific clinical 
signs (Arnold et al., 2010; Elce, 2006; Mair & Sherlock, 2011; 
Zicker et al., 1990). Treatment requires prolonged systemic 
antibiotic therapy or surgical intervention (Berlin et al., 2013; 
Elce, 2006; Mair & Sherlock, 2011).
Horses with abdominal abscesses often present with a 
history of colic, fever, weight loss, depression, and anorexia 
(Arnold & Chaffin, 2012; Elce, 2006). The survival rate 
varies between 24.6% to 80% and is apparently related to 
the presence of complications such as adhesions and the 
severity of the inflammatory response (Berlin et al., 2013).
The use of intraperitoneal route for ceftriaxone administration 
in horses has recently been described by Alonso et al. (2017, 
2018), and prolonged use of metronidazole without occurrence 
of adverse effects is reported as effective in abdominal abscesses 
treatment (Sweeney et al., 1991). The aim of this report is 
to describe a successful medical management of peritonitis 
and abdominal abscess with an association of intraperitoneal 
ceftriaxone, systemic gentamicin, and metronidazole.
Case Report
A 6-year-old gelding quarter horse with a history of 
colic and abdominal distension was seen on the farm by a 
veterinarian who performed multiple bilateral abdominal 
punctures to relieve gas distention. The punctures were 
performed without clipping and antisepsis, and with 
extravasation of fecal contents. According to the owner, 
no diagnosis was performed by the veterinarian, and there 
was a full recovery of the animal from the colic, yet five 
days later, apathy and significant decrease in food intake 
was observed. The animal was treated for gastritis with 
once daily oral omeprazol (4mg/Kg). Due to lack of clinical 
improvement, the owner chose to refer the animal to the 
veterinary hospital. The referral occurred nine days after 
the multiple abdominal punctures.
At admission, tachycardia (72 bpm), tachypnea (36 mpm), 
hyperthermia (39.0°C), mildly congested mucosa, 3-second 
capillary filling time, intestinal hypomotility, rigid gait, 
abdominal muscular tension line and normal pulmonary 
auscultation were observed. Rectal palpation was painful, 
although no more abnormalities were identified. Based 
on the history of previous colic with multiple abdominal 
punctures and clinical signs, peritonitis was suspected. 
Blood samples were harvested for white blood cell count, 
fibrinogen, renal and hepatic function evaluation, and 
abdominal sonography was performed. Peritoneal fluid 
harvest was unproductive in many attempts, including 
after systemic hydration.
White blood cell (WBC) count was within normal 
reference, but showed neutrophilia (8,300/μL) and intense 
hyperfibrinogenemia (1,200 mg/dL). Renal and hepatic 
functions were within normal reference and globulins 
increased (4.7 g/dL). Ultrasound examination revealed 
thickening of the wall of small (0.5 cm) and large intestine 
segments (0.4 cm), small amount of peritoneal fluid with 
increased echogenicity and the presence of a 5.99 cm 
diameter structure, with a heterogeneous appearance, and 
hyperechoic points inside (Figure 1). The structure was 
located in the region of the transition between dorsal and 
right ventral colon, occupying three intercostal spaces (ICS) 
(12° to 10 °ICS) and was compatible with an abdominal 
abscess. It was not possible to identify if the abscess was 
attached to the right ventral or dorsal colon. However, the 
persistent location in subsequent sonographic examinations 
suggested a right dorsal colon fixation, since this structure 
is fixed.
Although peritoneal fluid collection was unproductive 
at admission, ultrasonographic findings associated with 
clinical manifestation, fibrinogen and subsequent peritoneal 
fluid collections were consistent with the tentative diagnosis 
of diffuse peritonitis associated with abdominal abscess 
formation.
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An aggressive and immediate antimicrobial therapy, 
consisting of intravenous gentamicin (6.6 mg/Kg SID 7 days), 
intraperitoneal ceftriaxone (25 mg/Kg SID 7 days) and oral 
metronidazole (15 mg/kg TID 12 days; 15 mg/kg BID 33 days) 
was started in association with flunixin meglumine 
(1.1 mg/kg IV SID 3 days) and hydroelectrolytic repository.
Prior to ceftriaxone intraperitoneal administration, the 
skin of the left paralumbar fossa was clipped, the thickness of 
abdominal wall was measured by ultrasound and routinely 
antisepsis performed. The dosage of 25 mg/Kg was prepared 
in 250 mL of saline solution. Abdominal wall and skin 
were anesthetized with 10mL of lidocaine and access was 
performed with the stylet of a 14 G catheter. After skin 
transposition, one drop of solution was applied inside the 
catheter and then progressively introduced until reaching the 
abdominal cavity. Due to negative pressure, the solution was 
aspirated at the moment of abdominal access indicating the 
position where the solution could be coupled to the catheter 
(Figure 2). Intraperitoneal ceftriaxone administration was 
repeated for 7 days, respecting the interval of doses of 24 h 
established by Alonso et al. (2018).
After 24 h of treatment, no hyperthermia was observed 
(38.1°C), there was progressive improvement of the clinical 
signs, represented by increase of appetite, absence of 
abdominal stiffness and normalization of vital parameters 
(heart rate: 40 bpm; respiratory rate: 12 mpm; capillary 
refill time: 2 sec) and intestinal motility.
On the fifth day of treatment, peritoneal fluid was 
with 15.500 nucleated cells/µL with a predominance of 
segmented neutrophils (11,625/µL), followed by typical 
lymphocytes (2,790/µL), monucleated cells (930/µL) and 
macrophages (155/µL). At this time, hyperfibrinogenemia 
(600 mg/dL) was maintained, though with a 50% reduction 
in relation to the initial value (Figure 3). Seven days after 
the beginning of the treatment, peritoneal fluid was 
with 7,500 nucleated cells/µL and with a predominance 
of segmented neutrophils (4,575/µL), followed by typical 
lymphocytes (1,875/µL) and monucleated cells (1,050/µL). 
Due to the maintenance of clinical parameters within the 
reference normality and reduction of nucleated cell count 
to less than 10,000 cells/μL, and no ultrasonographic signs 
of diffuse peritonitis, ceftriaxone and gentamicin were 
discontinued, patient monitoring was performed until 
day 10 of treatment with metronidazole. At day 10, the 
abscess presented the same structural characteristic, but 
with a reduction of its diameter to 3.87 cm. The animal 
was discharged, with prescription of metronidazole for a 
total of 30 days and return for reevaluation.
At the 12th day of treatment, at the property, the owner 
reported the occurrence of softening feces, with no evident 
signs of dehydration, apathy, or increased defecation 
Figure 1 – Ultrasonographic findings. (A) thickening of the wall of the right ventral colon-RVC (0.42 cm) at admission; (B) thickening 
of the wall of the small intestine-SI (0.56 cm) at admission; (C) Abscess at the first day of treatment (5,99 cm); (D) view 
of the abscess at 11th ICS region after 30 days of treatment (2,92 x 2,81 cm) – heterogeneous structure with hyperechoic 
points; (E) view of the abscess at 12th ICS region after 30 days of treatment (2,48 x 1,17 cm) – homogeneous structure; 
(F) view of the abscess at the 12th ICS region at the 45th day of treatment (1,71 x 0,74 cm) – homogeneous structure. 
RDC-Right dorsal colon; SI-Small intestine.
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frequency. WBC count, fibrinogen, liver, and renal function 
was evaluated in the property and all values were within 
normal values. Administration of metronidazole was 
maintained at the same dose, administered every 12 h. 
After the change, there was feces normalization.
After 30 days of treatment, a hospital re-evaluation was 
performed. WBC count was normal, although with neutrophilia 
(8,100/μL), fibrinogen was 400 mg/dL (Figure 3), creatinine, 
aspartate aminotransferase and alkaline phosphatase were 
within normal reference, but urea (55 mg/dL) and gamma 
glutamyl transferase (44.7 IU/L) were slightly increased. 
Peritoneal fluid presented 4.400 nucleated cells/µL with 
a predominance of segmented neutrophils (3,476/µL), 
followed by typical lymphocytes (528/µL). Ultrasound 
examination revealed no inflammatory alterations in the 
abdominal cavity. It was possible to observe the abscess 
in 2 ICS (12th and 11th) and its diameter was reduced 
Figure 2 – Intraperitoneal ceftriaxone administration. (A) Abdominal wall ultrasonographic measurement (arrow); (B) Lateral 
view of the animal with the left paralumbar fossa clipped and prepared for administration; (C) Local anesthetic block; 
(D) Progressive introduction of 14G catheter in order to identify the access to abdominal cavity; (E) Ceftriaxone solution 
administration.
Figure 3 – Fibrinogen evolution during treatment period.
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to 2.92 x 2.81 cm in the 11th ICS and 2.48 x 1.17 cm in 
the 12th ICS (Figure 2). Only in the 11th ICS was it possible 
to observe the presence of hyperechoic points inside the 
abscess, and in the 12th ICS region it was possible to observe 
only a homogeneous structure compatible with fibrosis of 
the healing process.
Due to maintenance of the abscess in the 11th ICS, and 
the favorable clinical and ultrasonographic response to 
the adopted therapy, metronidazole was maintained and a 
new return was requested in 15 days. In the re-evaluation, 
WBC count was within normal limits; peritoneal fluid 
with 1,600 nucleated cells/µL with a predominance of 
segmented neutrophils (1,088/µL), followed by monucleated 
cells (336/µL), macrophages (112/µL) and typical lymphocytes 
(64/µL) renal and hepatic function were within normal 
values. Ultrasonographic examination showed only 
one small homogeneous structure of 1.71 x 0.74 cm in 
diameter in the region of the 12th ICS (Figure 2). Treatment 
with metronidazole was discontinued, and the disease 
was considered resolved. Through telephone contact 
after 12 months of treatment discontinuation no clinical 
abnormalities were reported.
Discussion
Abdominal abscesses can develop from different 
etiologies, being classified as primary or secondary. In the 
primary form, the abscesses originate from hematogenous 
or lymphatic spread, and in the secondary form, due to 
abdominal traumatic perforations, ulcers, gastrointestinal 
tract necrosis or after exploratory celiotomy (Arnold & 
Chaffin, 2012; Berlin et al., 2013; Elce, 2006). It is believed 
that the development of the abscess was secondary, and 
due to multiple abdominal punctures performed during 
colic treatment. Since the abdominal punctures were 
realized bilaterally and in many positions of the abdomen, 
the location of the abscess should be varied. Nine days is 
a compatible time for the development of an abdominal 
abscess, and is considered a short evolution, which can 
be compatible with a conservative approach (Berlin et al., 
2013; Elce, 2006).
In spite of the non-realization of the peritoneal fluid 
culture, it is important to recognize the main associated 
agents with abdominal abscesses and peritonitis in order to 
choose the best therapeutic approach. The most common 
agents associated with abscess formation in adult horses are 
Streptococcus equi, Streptococcus equi subsp zooepidemicus, 
Corynebacterium spp., Rhodococcus equi, Enterobacteriaceae 
and strict anaerobes (Bacteroides spp., Fusobacterium 
necrophorum, and Clostridium spp.) (Berlin et  al., 2013; 
Mair & Sherlock, 2011; Mogg & Rutherford, 2006). Despite 
the higher prevalence of Streptococcus equi as an etiological 
agent of abdominal abscesses in horses (Berlin et al., 2013; 
Elce, 2006; Mair & Sherlock, 2011; Pusterla et al., 2007), its 
etiology is associated with hematogenous dissemination 
in cases of strangles (Elce, 2006; Pusterla et al., 2007), not 
compatible with the animal history in this case.
Imprudent drainage of abdominal gas may result in the 
development of peritonitis and abdominal abscesses as a 
result of contamination by skin colonizing agent or intestinal 
bacterial flora (Unger  et  al., 2014). Thus, the previous 
colic episode with multiple abdominal punctures without 
clipping and antisepsis, and with extravasation of fecal 
contents, suggested that the etiological agent of peritonitis 
and abdominal abscess may arise from skin colonizing 
agents such as Staphylococcus spp. and Corynebacterium 
pseudotuberculosis (White & Yu, 2006) and from intestinal 
bacterial flora, such as Bacteroides spp., Clostridium spp., 
and Escherichia coli (Elce, 2006). The analysis and culture 
of the peritoneal fluid would be fundamental to define the 
etiologic agent; however it was unproductive.
The diagnosis of abdominal abscesses is challenging 
due to anatomical location and nonspecific clinical signs, 
such as colic, hyperthermia, weight loss, depression, 
lethargy, anorexia, tachycardia, and tachypnea (Arnold 
& Chaffin, 2012; Mair & Sherlock, 2011; Zicker  et  al., 
1990). In addition to the classic signs, abdominal stiffness 
and reluctance to locomotion were observed. Observed 
clinical signs were compatible with those previously 
described (Aleman  et  al., 2003; Mair & Sherlock, 2011; 
Pusterla et al., 2007; Rumbaugh et al., 1978; Sweeney et al., 
1986). The diagnosis of abdominal abscesses is based on 
clinical signs, rectal palpation, ultrasonographic findings, 
peritoneal fluid analysis, WBC count and surgical approach 
(Berlin et al., 2013). In the present case, the association of 
history, clinical, laboratorial and ultrasonographic findings 
allowed the diagnosis of diffuse septic peritonitis and 
abdominal abscess.
Abdominal abscesses are described in the liver, mesenteric 
lymph nodes, kidneys, spleen, uterus, bladder, intestine 
and abdominal wall (Berlin et al., 2013). Ultrasonographic 
examination detected the presence of diffuse peritonitis, 
with thickening of the intestinal walls and increased 
echogenicity of the peritoneal fluid and the presence of 
abdominal abscess adjacent to the right dorsal colon in the 
middle third of the right abdomen. Mair & Sherlock (2011) 
described six cases of abdominal abscess in adult horses 
with a variable location between jejunum, ileum, mesenteric 
root, and cecum, in which, according to the authors, all 
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abscesses were identified through rectal palpation and 
at ultrasound. In the present case, the identification was 
exclusively identified via ultrasonographic examination, 
due to its cranial location.
WBC count showed total leukocytes within the normal 
range, but with neutrophilia and hyperfibrinogenemia. 
According to Jacobsen et al. (2009), in cases of chronic 
inflammatory response, fibrinogen reflects more clearly the 
intensity of the inflammatory process than the peripheral 
leukocyte count. Fibrinogen is an acute phase protein 
widely used for monitoring the therapeutic response in 
cases of abdominal abscess (Berlin  et  al., 2013; Mair & 
Sherlock, 2011).
Abdominal abscess treatment requires prolonged 
systemic antibiotic therapy (Berlin et al., 2013; Elce, 2006) 
or surgical excision, drainage, and lavage procedure (Mair 
& Sherlock, 2011) or marsupialization (Prades et al., 1989; 
Rigg et al., 1987). The success rate of conservative or surgical 
therapy ranges from 24.6 to 100% and is related to the 
occurrence of complications such as adhesion formation 
and diffuse peritonitis (Berlin et al., 2013; Mair & Sherlock, 
2011). Pusterla  et  al. (2007) obtained 40% success with 
the conservative treatment of 10 horses with abdominal 
abscesses due to Streptococcus, and Berlin  et  al. (2013) 
obtained 100% success in 4 horses with Streptococcus 
secondary abscesses treated with penicillin G. Mair & 
Sherlock (2011) obtained 66.7% success, performing 
drainage and abdominal lavage in 6 horses. The absence 
of an exudative peritonitis, with increased free peritoneal 
fluid and debris supported the decision to institute antibiotic 
therapy without abdominal lavage.
It is described that the location, time of evolution and 
size of the abscess can interfere in the results obtained in the 
conservative treatment (Mair & Sherlock, 2011). According to 
Haggett & Wilson (2008) and Mair & Sherlock (2011), medical 
treatment of large abscesses (≥ 15-20 cm) is not effective 
due to the difficulty of antibiotics penetration, requiring 
surgical removal. Yet Berlin  et  al. (2013) demonstrated 
efficacy of conservative therapy even in abscesses with a 
diameter between 15 and 25 cm.
Although surgical removal results in a reduction of 
antibiotic therapy duration (Blot & Dewaele, 2005; Elce, 
2006), the conservative approach was chosen, considering 
the short time of disease evolution, which favors the 
penetration of antimicrobials and the difficult surgical 
approach of the right dorsal colon. The presence of diffuse 
and active peritonitis favored the choice of clinical therapy. 
Controlled clinical trials are necessary to compare surgical 
and conservative approaches of abdominal abscesses. In the 
absence of these studies, it is difficult to compare the merits 
and efficacy of both therapeutic options.
The treatment of abdominal abscesses in horses has 
previously been described with ceftiofur, rifampicin, 
potentiated sulfonamides, chloramphenicol, gentamicin, 
and metronidazole (Aleman et al., 2003; Elce, 2006; Haggett 
& Wilson, 2008; Mogg & Rutherford, 2006; Pusterla et al., 
2007). Due to the high occurrence of abdominal abscesses 
secondary to hematogenous spread of Streptococcus equi in 
cases of strangles, treatment with penicillin (Berlin et al., 
2013) and combination of sulfonamide potentiated and 
rifampicin (Haggett & Wilson, 2008; Pusterla et al., 2007) 
are more frequently used. In spite of the described low 
penetration of penicillin, Berlin et al. (2013) used penicillin 
G at a dose of 44.000 IU/kg and obtained 100% therapeutic 
success in 4 animals with abscesses secondary to strangles.
The adopted therapeutic strategy was based on the 
association of antimicrobials to obtain a broad spectrum of 
action, with coverage for gram positive, gram negative and 
anaerobic bacteria. The therapy consisted of ceftriaxone, 
gentamicin, and metronidazole combination.
Ceftriaxone is a third-generation cephalosporin 
that has a broad antibacterial spectrum, acting against 
gram-positive, gram-negative, and certain anaerobic 
bacteria. It has established clinical efficacy, and excellent 
penetration and therapeutic concentration in most body 
fluids (Alonso et al., 2018; Bijie et al., 2005; Lamb et al., 
2002; Ringger et al., 1996, 1998). The best therapeutic 
results are obtained when a dose regimen that results in 
high concentrations of the drug at the site of infection, 
above the minimum inhibitory concentration (MIC) 
for prolonged periods is used (Alonso  et  al., 2018; 
Levison & Levison, 2009). According to Alonso et al. 
(2018) ceftriaxone intraperitoneal administration results 
in concentrations above the MIC for enterobacteria 
for 24 h in the peritoneal fluid of healthy horses. 
In order to provide high and long-lasting antimicrobial 
concentrations in the peritoneal fluid, daily ceftriaxone 
was given intraperitoneally.
Gentamicin was added to the treatment because of 
its established efficacy against gram-negative bacteria 
(Haggett & Wilson, 2008). Despite the known limitation of 
gentamicin penetration into abscesses (Haggett & Wilson, 
2008; Jones et al., 1998), it was used due to the presence of 
associated diffuse and active peritonitis and earlier treatment. 
Administration of gentamicin occurred systemically, due 
to the absence of controlled studies evaluating its use by 
the intraperitoneal route.
7/9
Braz J Vet Res Anim Sci. 2020;57(2):e166204
Due to the history of fecal extravasation and the 
high prevalence of anaerobic bacteria in intestinal flora, 
metronidazole was added to therapy with the objective 
of action against anaerobic and due to its wide tissue 
distribution and penetration in abscesses (Aleman et al., 2003; 
Baggot et al., 1998; Haggett & Wilson, 2008; Specht et al., 
1992; Steinman et al., 2000; Sweeney et al., 1986).
Appropriate duration of antimicrobial therapy in cases of 
abdominal abscess is not known, and the range of treatment 
durations are described as 35 days (Berlin et  al., 2013); 
47 days (Mair & Sherlock, 2011); 72 days (Pusterla et al., 
2007); and three months in an isolated case (Aleman et al., 
2003). Therapy discontinuation should be based on clinical 
evolution, fibrinogen, WBC count, abdominal sonography, 
rectal palpation, and laparoscopy (Elce, 2006; Mair & 
Sherlock, 2011).
Gentamicin and ceftriaxone therapy lasted 7 days. Clinical 
improvement was observed after 12 h of the institution 
of antimicrobial therapy and support, such as return of 
appetite, alertness, and reduction of locomotion stiffness. 
The occurrence of adverse effects to antimicrobial therapy 
was observed after 12 days of therapy, with the occurrence 
of feces softening, with no signs of dehydration, apathy, 
or increased defecation frequency. After increasing the 
interval of metronidazole doses, feces returned to normal.
Although fecal softening occurred on the 12th day of 
metronidazole treatment, it cannot be inferred that the 
occurrence of this adverse effect was exclusively due to the 
use of metronidazole. Diarrhea secondary to antimicrobial 
use is described during and after the discontinuation of 
these drugs (Barr et al., 2013), and it is believed that the 
association of the antibiotics may have contributed to the 
imbalance of the intestinal flora.
In a retrospective study evaluating the use of metronidazole 
in 200 horses with various infectious processes, including 39 cases 
of peritonitis and / or abdominal abscess, anorexia was 
observed in 4/200 animals as an adverse effect and whose 
resolution occurred after discontinuation of treatment 
(Sweeney  et  al., 1991). Cypher  et  al. (2015) described 
the use of metronidazole (25 mg/kg - VO - TID) for the 
treatment of hepatic abscess in a horse for 10 days; however, 
it was discontinued after signs of anorexia. No previous 
studies reported the occurrence of diarrhea after prolonged 
metronidazole therapy.
Intraperitoneal ceftriaxone administration at a dose 
of 25 mg/kg for 5 days did not result in adverse effects in 
the study of Alonso et al. (2018) and gentamicin despite 
known nephrotoxicity (Haggett & Wilson, 2008) did not 
result in adverse effects. Corroborating with the possibility 
that the association of the drugs have triggered the intestinal 
flora imbalance.
The long-term use of metronidazole is poorly reported 
in horses (Sweeney et al., 1991), although it is widely used 
in medicine (Mikamo et al., 2015, 2016; Smith et al., 1983). 
After feces normalization at the 14th day of treatment, no 
clinical or laboratorial adverse effects were observed until 
the 45th day of treatment and progressive regression of 
abscess size was obtained.
Abdominal sonography, fibrinogen, leukocyte count and 
nucleated cells in the peritoneal fluid allow strict control 
of the evolution of the disease, emphasizing abdominal 
ultrasonography and fibrinogen evolution for the decision 
to treatment discontinuation. Abdominal ultrasound 
examination revealed reduction of abscess size and acquired 
hyperechoic and homogeneous aspect, suggesting resolution 
of infection and fibrosis.
Although the collection of peritoneal fluid was 
not productive at hospital admission and prior to the 
installation of therapeutic management, the evolution 
of nucleated cell counts throughout the treatment period 
demonstrated the presence of peritonitis, and a favorable 
response to therapy.
Based on the clinical, laboratorial and sonographic 
findings, it was possible to identify resolution of the diffuse 
peritonitis during hospitalization (10 days). The favorable 
evolution obtained in a short period of treatment of the 
abscess is highlighted when compared to the average duration 
of the therapies. Furthermore, abdominal sonography 
and plasma concentration of fibrinogen were decisive for 
monitoring resolution of the abdominal abscess.
Due to the impossibility of identifying the etiological 
agent, it is difficult to attribute the result obtained to the 
use of a specific drug. However, the rapid recovery after 
association of the drugs is emphasized and a favorable evolution 
continues after exclusive maintenance of metronidazole. 
Studies are required using these drugs in combination or 
alone and by different routes in a larger number of animals 
in order to support the indication of this therapy.
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